DJIA 16,677.90 216.58 1.32%
NASDAQ 4,452.79 69.95 1.60%
S&P 500 1,950.82 23.71 1.23%
market minute promo

GlaxoSmithKline (NYSE: GSK)

45.36 0.95 (2.14%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GSK $45.36 2.14%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $45.09
Previous Close $44.41
Daily Range $44.95 - $45.59
52-Week Range $41.91 - $56.73
Market Cap $109.0B
P/E Ratio 15.26
Dividend (Yield) $2.59 (6.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 5,713,331
Average Daily Volume 6,479,431
Current FY EPS $3.09





GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website:

News & Commentary

3 Beaten Down Biotech Stocks to Buy Now

The share prices of Dynavax Technologies, CellDex Therapeutics, and Clovis Oncology have all plunged this year. Here is why I think these beaten down biotechs are now compelling buys.

What GSK's Q3 Results Mean For Theravance

Best European Stock Ideas Today 10/23/2014

Tesco slumps; Novozymes rallies: Europe’s big stock movers

Tesco slumps, sends FTSE lower for first time in three days

GlaxoSmithKline's (GSK) CEO Andrew Witty on Q3 2014 Results - Earnings Call Transcript

Key Takeaways From GlaxoSmithKline's Third-Quarter Earnings

British Pharma GlaxoSmithKline reported third-quarter earnings this morning. Here's what you need to know.

3 Drugs Stocks Pushing The Industry Higher

3 Biotech Stocks Near 52-Week Highs Worth Selling

Three Motley Fool analysts weigh in on which stocks they think should be sold near their highs.

GlaxoSmithKline (GSK) Is Today's Pre-Market Mover With Heavy Volume Stock

See More GSK News...

GSK's Top Competitors

GSK $45.36 (2.14%)
Current stock: GSK
NVS $89.24 (1.18%)
Current stock: NVS
PFE $28.60 (1.06%)
Current stock: PFE
JNJ $102.63 (1.39%)
Current stock: JNJ